Skip to main content
. Author manuscript; available in PMC: 2017 Oct 19.
Published in final edited form as: Lancet Oncol. 2017 Mar 2;18(3):e143–e152. doi: 10.1016/S1470-2045(17)30074-8

Figure 2. RECIST 1.1 and iRECIST: an example of assessment.

Figure 2

Prefix “i” indicates immune responses assigned using iRECIST; others without “i” are confirmed by RECIST 1.1. RECIST=Response Evaluation Criteria in Solid Tumours. iCR=complete response. iCPD=complete progression. iPR=partial response. iSD=stable disease. iUPD=unconfirmed progression. TP=timepoint.